Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk
Authors:
Open Access
- 21 June 2018
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 61 (9) , 2043-2053
Abstract
Aims/hypothesis We hypothesised that progression of islet autoimmunity and type 1 diabetes mellitus differs among races/ethnicities in at-risk individuals. Methods In this study, we analysed the data from the Type 1 Diabetes TrialNet Pathway to Prevention Study. We studied 4873 non-diabetic, autoantibody-positive relatives of individuals with type 1 diabetes followed prospectively (11% Hispanic, 80.9% non-Hispanic white [NHW], 2.9% non-Hispanic black [NHB] and 5.2% non-Hispanic other [NHO]). Primary outcomes were time from single autoantibody positivity confirmation to multiple autoantibody positivity, and time from multiple autoantibody positivity to type 1 diabetes mellitus diagnosis. Results Conversion from single to multiple autoantibody positivity was less common in Hispanic individuals than in NHW individuals (HR 0.66 [95% CI 0.46, 0.96], p = 0.028) adjusting for autoantibody type, age, sex, Diabetes Prevention Trial Type 1 Risk Score and HLA-DR3-DQ2/DR4-DQ8 genotype. In participants who screened positive for multiple autoantibodies (n = 2834), time to type 1 diabetes did not differ by race/ethnicity overall (p = 0.91). In children who were p = 0.024) and was nearly quadrupled in Hispanic children (HR 3.8 [95% CI 1.6, 9.1], p = 0.0026). We did not observe this interaction in participants who were ≥12 years old at determination of autoantibody positivity, although this group size was limited. No significant differential risks were observed between individuals of NHB and NHW ethnicity. Conclusions/interpretation The risk and rate of progression of islet autoimmunity were lower in Hispanic compared with NHW at-risk individuals, while significant differences in the development of type 1 diabetes were limited to children <12 years old and were modified by BMI.Keywords
Funding Information
- NIH (U01 DK103180-01)
This publication has 36 references indexed in Scilit:
- Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic FactorsDiabetes Care, 2018
- Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?The Journal of Clinical Endocrinology & Metabolism, 2017
- Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002–2012New England Journal of Medicine, 2017
- Genetic susceptibility to type 1 diabetes in childhood - estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunityPediatric Diabetes, 2016
- Prognostic Classification Factors Associated With Development of Multiple Autoantibodies, Dysglycemia, and Type 1 Diabetes—A Recursive Partitioning AnalysisDiabetes Care, 2016
- Characteristics of rapid vs slow progression to type 1 diabetes in multiple islet autoantibody-positive childrenDiabetologia, 2013
- Insights into type 1 diabetes provided by genetic analysesCurrent Opinion in Endocrinology, Diabetes and Obesity, 2012
- The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial resultsPediatric Diabetes, 2009
- Type 1 Diabetes TrialNet–An International Collaborative Clinical Trials NetworkAnnals of the New York Academy of Sciences, 2008
- Life table analysis of the risk of Type 1 (insulin-dependent) diabetes mellitus in siblings according to islet cell antibodies and HLA markersDiabetologia, 1992